SCHEMBL16416339

SCHEMBL16416339

CN1CCN(c2ccc3ccn(C(N)=O)c3n2)CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 15/20 1.00
▸ KDM4E B2RXH2 2/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ HTR3A P46098 2/20 0.46
▸ HRH4 Q9H3N8 2/20 0.46
▸ HRH3 Q9Y5N1 2/20 0.46
▸ HTR3E A5X5Y0 1/20 0.46
▸ HTR3B O95264 1/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ THPO P40225 1/20 0.46
▸ HTR3D Q70Z44 1/20 0.46
▸ HTR3C Q8WXA8 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16416386 0.87 PARP1 (1.00) PARP1
SCHEMBL16416586 0.86 PARP1 (1.00) PARP1ALDH1A1
SCHEMBL13835404 0.70 PARP1 (0.54) PARP1KDM4EALDH1A1HTR3AHRH4
SCHEMBL29767985 0.69 IRAK4 (0.57) PARP1
SCHEMBL16416477 0.69 PARP1 (0.58) PARP1
SCHEMBL15652284 0.69 HTR3A (0.58) PARP1KDM4EALDH1A1HTR3AHRH4
SCHEMBL16621461 0.69 HTR3A (0.60) PARP1KDM4EALDH1A1HTR3AHRH4
SCHEMBL21274069 0.69 PARP1 (0.52) PARP1KDM4EALDH1A1HTR3AHRH4
SCHEMBL25138077 0.68 HTR3A (0.70) PARP1KDM4EALDH1A1HTR3AHRH4
SCHEMBL8802140 0.67 HTR3A (0.53) PARP1KDM4EALDH1A1HTR3AHRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015011008-A1 7-AZAINDOLE DERIVATIVES AS PARP INHIBITORS SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2015-01-29 — — WO claimed
WO-2015011008-A1 7-AZAINDOLE DERIVATIVES AS PARP INHIBITORS SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2015-01-29 — — WO disclosed
Send feedback